Hypertension is a frequent complication during induction therapy for pediatric ALL, occurring in nearly 20% of patients, with younger age and B-cell ALL identified as potential risk factors.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Goel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: